NEW ENTERPRISE ASSOCIATES 13 LP's Net Worth
$682 Million
Who is NEW ENTERPRISE ASSOCIATES 13 LP?
NEW ENTERPRISE ASSOCIATES 13 LP has an estimated net worth of $682 Million. This is based on reported shares across multiple companies, which include Sagimet Biosciences Inc., Cloudflare, Inc., RHYTHM PHARMACEUTICALS, INC., TESARO, Inc., Workday, Inc., Care.com Inc, Millennial Media Inc., AEROHIVE NETWORKS, INC, BuzzFeed, Inc., Sprout Social, Inc., Clovis Oncology, Inc., BOX INC, Coursera, Inc., Dermira, Inc., PhaseBio Pharmaceuticals Inc, GLYCOMIMETICS INC, Epizyme, Inc., MINERVA SURGICAL INC, Roka BioScience, Inc., Omthera Pharmaceuticals, Inc., Ra Pharmaceuticals, Inc., and CVENT INC.
SEC CIK
NEW ENTERPRISE ASSOCIATES 13 LP's CIK is 0001452907
Past Insider Trading and Trends
2014 was NEW ENTERPRISE ASSOCIATES 13 LP's most active year for acquiring shares with 16 total transactions. NEW ENTERPRISE ASSOCIATES 13 LP's most active month to acquire stocks was the month of September. 2014 was NEW ENTERPRISE ASSOCIATES 13 LP's most active year for disposing of shares, totalling 21 transactions. NEW ENTERPRISE ASSOCIATES 13 LP's most active month to dispose stocks was the month of September. 2016 saw NEW ENTERPRISE ASSOCIATES 13 LP paying a total of $39,405,647.57 for 11,034,334 shares, this is the most they've acquired in one year. In 2020 NEW ENTERPRISE ASSOCIATES 13 LP cashed out on 89,753,063 shares for a total of $94,650,765.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Cloudflare, Inc. (NET) Snapshot price: $75.98
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
| 2.76M |
Nov 11
| |||
Form 4
| -31.92% | -1.30M |
—
|
—
| 2.76M |
Aug 7
| |||
Form 4
|
—
|
0
|
—
|
—
| 4.06M |
May 19
| |||
Form 4
|
∞
| 4.06M |
—
|
—
| 4.06M |
Sep 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PhaseBio Pharmaceuticals Inc (PHASQ) Snapshot price: $0.000001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -26.86% | -1.78M |
$0.15 | -$262,264.02 | 4.86M |
Oct 25
| |||
Form 4
|
∞
| 6.64M |
$5.00 |
—
| 6.64M |
Oct 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Ra Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.14M |
—
|
—
|
0
|
Apr 2
| |||
Form 4
| +11.75% | 645.16K |
$15.50 | $9,999,995.50 | 6.14M |
Dec 14
| |||
Form 4
| +57.31% | 2M |
$6.00 | $12,000,000.00 | 5.49M |
Feb 16
| |||
Form 4
|
∞
| 3.49M |
$11.76 | -$5,655.00 | 3.49M |
Oct 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Sprout Social, Inc. (SPT) Snapshot price: $27.08
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -44.78% | -2.50M |
—
|
—
| 3.08M |
Nov 13
| |||
Form 4
| -38.14% | -3.44M |
$27.50 | -$94,650,765.00 | 5.58M |
Aug 17
| |||
Form 4
|
∞
| 9.02M |
—
|
—
| 9.02M |
Dec 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
GLYCOMIMETICS INC (GLYC) Snapshot price: $0.1596
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.09M |
$8.00 |
—
| 4.09M |
Jan 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |